--:--:--
Stockwatch Reports
…

News Reports / Healthcare / ACHC

ACHCAcadia Healthcare Company, Inc.

NasdaqGS · Healthcare · Mkt cap $3.2B · Avg vol 1.61M

$34.79

+2.54 (+7.88%)

Quote as of November 5, 2026, 6:25 PM ET

News Impact Report · Published November 5, 2026, 2:55 PM ET

ACHC: Acadia Healthcare Posts $2.49B in Q3 FY2026 Revenue as Net Income Narrows to $8.4M

Share

Ticker: ACHC | Filing: 10-Q | Filed with the SEC: November 4, 2026 | Current Price: $35.60 (+10.39% today)


What Happened

Acadia Healthcare Company, Inc. filed its quarterly report on Form 10-Q with the SEC on November 4, 2026, covering the third quarter of fiscal year 2026. The filing reveals revenue of $2,491,310,000 ($2.49 billion) for Q3 FY2026, while net income came in at $8,374,000 ($8.4 million), producing basic and diluted earnings per share of $0.82. The combination of substantial top-line revenue alongside a comparatively thin net income figure suggests meaningful cost pressure or non-operating charges weighing on the bottom line during the quarter.


Why It Matters

For investors, the key tension in this filing is the stark gap between Acadia's large revenue base — $2.49 billion in a single quarter — and the relatively modest net income of $8.4 million. This implies a net profit margin of well under 1% for the quarter, which is a signal worth scrutinizing closely. While revenue at this scale reflects the breadth of Acadia's behavioral health facility network, the slim bottom-line result raises immediate questions about operating efficiency, cost management, interest expense, or one-time charges that may have compressed profitability. The stock's notable single-day move of +10.39% to $35.60 suggests the market may be responding positively to the revenue figure or to some aspect of the report not fully captured in the structured data provided — investors should review the full filing for commentary on margins and forward guidance. It is also worth noting that ACHC is currently trading well above the $26.50 price target established in StockWatch's initiating coverage published on September 9, 2026.


Analysis

The juxtaposition of a multi-billion-dollar revenue line with single-digit millions in net income is the defining feature of this quarter's report. Acadia operates in the behavioral health and psychiatric care space, a sector that tends to carry significant labor costs, facility overhead, and regulatory compliance expenses — all of which can erode margins even at high revenue volumes. The EPS of $0.82 (basic and diluted) is not negligible on its own, but in the context of $2.49 billion in revenue, it underscores how thin the margin structure is at present.

Key items to watch as investors digest this filing:

  • Margin trajectory: Whether operating costs are stabilizing or continuing to rise as a share of revenue.
  • Interest and debt costs: Given Acadia's capital-intensive business model, non-operating charges — particularly interest expense — could be a primary driver of the gap between operating performance and net income.
  • One-time items: Any litigation settlements, restructuring charges, or impairments disclosed in the filing narrative that may explain the compressed net result.
  • Full operating income context: The structured data includes an operating income figure of $136,003,000 attributed to Q1 FY2020, which does not correspond to the current reporting period and cannot be used as a current-period comparison — investors should consult the full 10-Q for current-period operating income disclosure.

The sharp stock rally today warrants attention: if the market is interpreting this report as a beat relative to expectations, the full filing's management discussion and any guidance language will be critical reading.


Disclaimer

This report is a news and informational summary based solely on data extracted from Acadia Healthcare's SEC filing and publicly available market data. It does not constitute investment advice, a recommendation to buy or sell any security, or an equity research report. No rating or price target is issued herein. Investors should conduct their own due diligence and consult a qualified financial professional before making any investment decisions.

Existing Coverage

StockWatch has full coverage on ACHC, published 2026-09-09. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-11-04. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1520697/000119312526447412/achc-20260930.htm

StockWatch initiated coverage · September 9, 2026

ACHC: Acadia Healthcare's Turnaround Amid Operational and Legal Headwinds

Severe Financial Distress: Acadia reported an EPS of -$12.42, reflecting substantial one-time charges, asset impairments, and legal settlement costs that have eroded shareholder value. The company's market cap stands at $2.7B, down significantly from its 52-week high of $35.83, underscoring the magnitude of the recent crisis. Intense Short Pressure: With 34.57% of the float shorted (20.95M shares as of Aug 14, 2026), the market is pricing in substantial downside risk or potential ba

+21.4%

Read the full report →

+21.4%

Key Data

Last

$35.60

P&L ($)

+$3.35

P&L (%)

+10.39%

Day Range

$33.84 - $39.38

Volume

3.39M

Market Cap

$3.2B

Previous Close

$32.25

Open

$37.18

52 Week Range

$11.43 - $39.38

Shares Outstanding

93.10M

Public Float

91.53M

Average Volume

1.61M

As of November 5, 2026, 5:12 PM ET

Advertise here
Stockwatch Reports

Free stock market updates, top gainers & losers, and AI-generated stock analyses — updated daily. Real-time price movements, quotes, and coverage for German & U.S. stoc